Literature DB >> 20978386

Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.

Supachai Rerks-Ngarm1, Punnee Pitisuttithum, Nirmal Ganguly, Linqi Zhang, Hiko Tamashiro, David A Cooper, Mean Chhi Vun, Budiman Bela, Rossana Ditangco, Nguyen Van Kinh, Alan Bernstein, Saladin Osmanov, Bonnie Mathieson, Stephen J Kent, Yiming Shao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20978386      PMCID： PMC3125721          DOI： 10.1097/COH.0b013e32833c95c1

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN： 1746-630X            Impact factor:   4.283


× No keyword cloud information.
  28 in total

1.  Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand.

Authors:  Piyanot Wirachsilp; Wannee Kantakamalakul; Suporn Foongladda; Thippawan Chuenchitra; Surapol Kohriangudom; Niracha Athipanyasilp; Sombat Tanprasertsuk; Malee Gasitrong; Ruengpung Sutthent
Journal:  Southeast Asian J Trop Med Public Health       Date:  2007-09       Impact factor: 0.267

2.  A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

Authors:  Anthony D Kelleher; Rebekah L Puls; Mark Bebbington; David Boyle; Rosemary Ffrench; Stephen J Kent; Sue Kippax; Damian F J Purcell; Scott Thomson; Handan Wand; David A Cooper; Sean Emery
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

3.  A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Authors:  Sanjay Mehendale; Jan van Lunzen; Nathan Clumeck; Jurgen Rockstroh; Eva Vets; Philip R Johnson; Pervin Anklesaria; Burc Barin; Mark Boaz; Sonali Kochhar; Jennifer Lehrman; Claudia Schmidt; Mathieu Peeters; Carolynne Schwarze-Zander; Kabeya Kabamba; Tobias Glaunsinger; Seema Sahay; Madhuri Thakar; Ramesh Paranjape; Jill Gilmour; Jean-Louis Excler; Patricia Fast; Alison E Heald
Journal:  AIDS Res Hum Retroviruses       Date:  2008-06       Impact factor: 2.205

4.  HIV vaccine trials in India.

Authors:  Seth Berkley
Journal:  Nat Biotechnol       Date:  2008-05       Impact factor: 54.908

Review 5.  HIV vaccine research in Thailand: lessons learned.

Authors:  Punnee Pitisuttithum
Journal:  Expert Rev Vaccines       Date:  2008-04       Impact factor: 5.217

6.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

7.  CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.

Authors:  Jun Liu; Qigui Yu; Geoffrey W Stone; Feng Yun Yue; Nicholas Ngai; R Brad Jones; Richard S Kornbluth; Mario A Ostrowski
Journal:  Vaccine       Date:  2008-06-02       Impact factor: 3.641

8.  Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Authors:  Ivan Stratov; Amy Chung; Stephen J Kent
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

9.  A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.

Authors:  Prasert Thongcharoen; Vinai Suriyanon; Robert M Paris; Chirasak Khamboonruang; Mark S de Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E Brown; Deborah L Birx; John G McNeil; Jerome H Kim
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09-01       Impact factor: 3.731

10.  Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood.

Authors:  Robert De Rose; Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Sheilajen Alcântara; Vivienne Peut; Erik Rollman; Liyen Loh; Rosemarie D Mason; Kim Wilson; Matthew G Law; Amanda J Handley; Stephen J Kent
Journal:  PLoS Pathog       Date:  2008-05-02       Impact factor: 6.823
View more
  6 in total

1.  Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Authors:  Hong Shang; Xiaoxu Han; Xuanling Shi; Teng Zuo; Mark Goldin; Dan Chen; Bing Han; Wei Sun; Hao Wu; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

2.  AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.

Authors:  Stephen J Kent; David A Cooper; Mean Chhi Vun; Yiming Shao; Linqi Zhang; Nirmal Ganguly; Budiman Bela; Hiko Tamashiro; Rossana Ditangco; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Nguyen Van Kinh; Alan Bernstein; Saladin Osmanov
Journal:  PLoS Med       Date:  2010-09-21       Impact factor: 11.069

Review 3.  Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature.

Authors:  Samuel R P Franzen; Clare Chandler; Trudie Lang
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

Review 4.  Functional nanomaterials can optimize the efficacy of vaccines.

Authors:  Ye Liu; Yingying Xu; Yue Tian; Chunying Chen; Chen Wang; Xingyu Jiang
Journal:  Small       Date:  2014-09-19       Impact factor: 13.281

5.  An HIV Vaccine for South-East Asia-Opportunities and Challenges.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Robert J O'Connell; Jerome H Kim; Jean-Louis Excler
Journal:  Vaccines (Basel)       Date:  2013-08-14

6.  Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.

Authors:  Dan Allman; Melissa Hope Ditmore; Karyn Kaplan
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.